Bank of America’s Nanobiotix NBTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-706
Closed -$2.53K 8573
2025
Q1
$2.53K Sell
706
-1,711
-71% -$5.91K ﹤0.01% 7307
2024
Q4
$6.94K Buy
2,417
+1,711
+242% +$6.85K ﹤0.01% 7047
2024
Q3
$4.06K Sell
706
-54
-7% -$281 ﹤0.01% 7043
2024
Q2
$3.8K Buy
760
+498
+190% +$3K ﹤0.01% 7059
2024
Q1
$1.7K Buy
262
+121
+86% +$856 ﹤0.01% 7143
2023
Q4
$1.03K Buy
+141
New +$893 ﹤0.01% 7197

Other funds holding NBTX

Bank of America's NBTX Position: Q2 2025 in Review

Bank of America sold out of Nanobiotix (NBTX) in Q2 2025, closing a stake of 706 shares — an estimated $2.53K sold.

Bank of America first reported a position in NBTX in Q4 2023 and held it in 6 quarters. The position peaked at $6.94K in Q4 2024. 10 funds tracked by Wall St. Rank hold NBTX as of Q2 2025.

  • Bank of America reported no remaining Nanobiotix position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 706 Nanobiotix shares in Q2 2025, an estimated $2.53K.
  • Bank of America first reported a position in Nanobiotix in Q4 2023 and held it in 6 quarters.
  • Bank of America's Nanobiotix position peaked at $6.94K in Q4 2024.
  • 10 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.